Shareholders that Lost Money on Merck & Co., Inc. (MRK) Should Contact Levi & Korsinsky about Pending Class Action - MRK
Portfolio Pulse from
A class action securities lawsuit has been filed against Merck & Co. alleging securities fraud related to Gardasil sales projections in China. The lawsuit claims Merck misrepresented expected revenue of $11 billion by 2030, with the stock dropping over 9% after announcing it would cease Gardasil shipments to China midyear due to lower-than-expected demand.
March 21, 2025 | 1:45 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Merck's stock price dropped over 9% following announcement of Gardasil shipment cessation in China and potential securities fraud allegations
The class action lawsuit directly targets Merck's representations about Gardasil sales, which caused significant stock price decline and potential financial liability
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100